Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).
about
Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 miceMutation of zebrafish dihydrolipoamide branched-chain transacylase E2 results in motor dysfunction and models maple syrup urine disease.Brain-blood amino acid correlates following protein restriction in murine maple syrup urine disease.Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.Branched-chain amino acid metabolism: from rare Mendelian diseases to more common disorders.The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.Effect of specific activation of γ-aminobutyric acid receptor in vivo on oxidative stress-induced damage after extended hepatectomy.Placental stem cell correction of murine intermediate maple syrup urine disease.Liver transplantation for classical maple syrup urine disease: long-term follow-up in 37 patients and comparative United Network for Organ Sharing experienceTherapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.Therapeutic liver repopulation for phenylketonuria.Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects.Hepatocyte transplantation for inherited metabolic diseases of the liver.
P2860
Q28703649-16983419-E6AF-484E-8881-21948E34DE7BQ30506049-0B9EE127-E644-4A29-87BD-030A05B313BCQ33617530-41D78C53-BDE1-4AFE-B6D8-F70185C44214Q33829216-B8C06AF1-25C8-4868-9833-DE0587DB0EA9Q34222287-72149829-8EFF-48B7-A916-2B1EA8724304Q35129278-22860258-FF2F-4A0E-B4D5-6451A85331C6Q36223599-67EAF4C1-2333-4F9A-832A-4C12C4F74A8CQ36672821-9682F2D8-282A-4F0C-9E16-24BC85D7F412Q36900920-F2EE422D-79C3-47BF-A5D6-99A4B12A9675Q37684677-BB2016B7-55AB-43FE-B40E-4A6AB0F7FB83Q37760081-CD0340C0-3CB9-430D-AD22-D06843B6E1C5Q37835047-9A51DC23-3EF6-4C19-B085-4D7A672B97F0Q38025743-CF2CE1E0-33E2-445A-ADA0-23BB0E1ECBD0
P2860
Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Hepatocyte transplantation (HT ...... e syrup urine disease (iMSUD).
@en
Hepatocyte transplantation
@nl
type
label
Hepatocyte transplantation (HT ...... e syrup urine disease (iMSUD).
@en
Hepatocyte transplantation
@nl
prefLabel
Hepatocyte transplantation (HT ...... e syrup urine disease (iMSUD).
@en
Hepatocyte transplantation
@nl
P2093
P2860
P1476
Hepatocyte transplantation (HT ...... e syrup urine disease (iMSUD).
@en
P2093
Cornelis Jakobs
Elizabeth J Hager
Erland Arning
Erwin E W Jansen
Harbhajan S Paul
K Michael Gibson
Kristen J Skvorak
Teodoro Bottiglieri
William J Zinnanti
P2860
P304
P356
10.1016/J.BBADIS.2009.08.006
P577
2009-08-19T00:00:00Z